HOULIHAN LOKEY, INC. HLI
NYSE · XNYS · stock · Investment Advice
Chart by TradingView
3/9
Piotroski F — financial health
—
Altman Z″ — distress risk
40.9%
Dividend payout · moderate
Financials (annual, from 10-K)
| FY | Revenue | Net income | Gross profit | Free cash flow | Equity |
|---|---|---|---|---|---|
| 2026 | $2.6B | $425.7M | — | $681.8M | $2.3B |
| 2025 | $2.4B | $399.7M | $772.3M | $808.9M | $2.2B |
| 2024 | $1.9B | $280.3M | $571.1M | $261.7M | $1.8B |
| 2023 | $1.8B | $254.2M | $557.1M | $85.5M | $1.6B |
| 2022 | $2.3B | $437.8M | $795.3M | $727.9M | $1.4B |
| 2021 | $1.5B | $312.8M | $521.4M | $565.7M | $1.4B |
Recent insider activity (Form 4)
| Insider | Role | Date | Action | Shares | Price |
|---|---|---|---|---|---|
| BEISER SCOTT L | CO-CHAIRMAN | 2026-05-21 | Conversion | 6,265 | — |
| BEISER SCOTT L | CO-CHAIRMAN | 2026-05-21 | Sell | 6,265 | $150.26 |
| Walker Cyrus D. | director | 2026-05-21 | Grant | 996 | — |
| Bassey Ekpedeme M | director | 2026-05-21 | Grant | 797 | — |
| Zucker Gillian Beth | director | 2026-05-21 | Grant | 996 | — |
| ZUBER PAUL ANDREW | director | 2026-05-21 | Grant | 797 | — |
| SCHRIESHEIM ROBERT A | director | 2026-05-21 | Grant | 1,129 | — |
Why these scores methodology →
Piotroski F-score: 3/9
- Positive return on assets
- Positive operating cash flow
- Rising ROA
- Cash flow exceeds net income
- Lower long-term debt
- Rising current ratio
- No share dilution
- Rising gross margin
- Rising asset turnover
Altman Z″: n/a
Not applicable (financials/insurer or missing inputs).
Source: SEC EDGAR filings · CIK 0001302215 · as of 2026-03-31. Figures are facts from filings plus Stocktoria's own computed scores — not investment advice.